Achillion Pharmaceuticals, Inc. Announces Executive Promotions  
10/20/2010 11:43:12 AM

NEW HAVEN, Conn., Oct. 20, 2010 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced two executive promotions. Milind S. Deshpande, Ph.D., has been promoted to President of Research and Development and retains his position as Chief Scientific Officer, and Mary Kay Fenton has been promoted to Senior Vice President and retains her position as Chief Financial Officer. Previously, Dr. Deshpande served as the Company's Executive Vice President of Research and Development and Ms. Fenton served as Vice President.